Back
Cartesian Therapeutics, Inc. RNAC · Insights
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies f... Price7.02
Market Cap214.13 M
Float14.04 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro